Warren Hamel and Maggie Grace published "The Fourth Circuit Limits FCA Liability in cGMP Cases" in Bloomberg BNA's Pharmaceutical Law & Industry Report on April 18, 2014.
Click to view "The Fourth Circuit Limits FCA Liability in cGMP Cases."
April 18, 2014 | Bloomberg BNA's Pharmaceutical Law & Industry Report
The Fourth Circuit Limits FCA Liability in cGMP Cases
1 min
Related Services
Practices
Related Insights
SEC Finalizes Rule That Affords PCAOB Oversight of Foreign Issuer Books and Raises the Specter of Delisting Non-Compliant Issuers
SEC Finalizes Rule That Affords PCAOB Oversight of Foreign Issuer Books and Raises the Specter of Delisting Non-Compliant Issuers
December 09, 2021
3min
Advertising Group Settles FCPA Charges with SEC
Advertising Group Settles FCPA Charges with SEC
November 11, 2021
6min
Life Sciences Anti-Corruption Enforcement Trends to Watch
Life Sciences Anti-Corruption Enforcement Trends to Watch
August 27, 2021
1min
Recent News
Max Wellman Joins Venable’s Commercial Litigation Practice in Los Angeles
Max Wellman Joins Venable’s Commercial Litigation Practice in Los Angeles
January 11, 2022
2min
Venable Assists Client Cobis Systems Corporation in the Sale of Controlling Interest
Venable Assists Client Cobis Systems Corporation in the Sale of Controlling Interest
January 10, 2022
1min
Managing Intellectual Property Quotes Meaghan Kent on Copyright Trends Shaping 2022
Managing Intellectual Property Quotes Meaghan Kent on Copyright Trends Shaping 2022
January 07, 2022
1min